1
Hunt, Barnaby, Malkin, Samuel J. P., Moes, Robert G. J., Huisman, Eline L., Vandebrouck, Tom, Wolffenbuttel, Bruce H. R.
Veröffentlicht in: Hunt , B , Malkin , S J P , Moes , R G J , Huisman , E L , Vandebrouck , T & Wolffenbuttel , B H R 2019 , ' Once-weekly semaglutide for patients with type 2 diabetes : a cost-effectiveness analysis in the Netherlands ' , BMJ Open Diabetes Research & Care , vol. 7 , no. 1 , 000705 . https://doi.org/10.1136/bmjdrc-2019-000705;
2019
Veröffentlicht in: Hunt , B , Malkin , S J P , Moes , R G J , Huisman , E L , Vandebrouck , T & Wolffenbuttel , B H R 2019 , ' Once-weekly semaglutide for patients with type 2 diabetes : a cost-effectiveness analysis in the Netherlands ' , BMJ Open Diabetes Research & Care , vol. 7 , no. 1 , 000705 . https://doi.org/10.1136/bmjdrc-2019-000705;
2019
2
Slot, Stefanie, Raymakers, Reinier A. P., Schaap, Nicolaas, Span, Lambert F. R., Koene, Harry R., Kersting, Sabina, Boekhorst, Peter A. W. te, Westerman, Matthijs, Schouten, Harry C., Zweegman, Sonja
Veröffentlicht in: Slot , S , Raymakers , R A P , Schaap , N , Span , L F R , Koene , H R , Kersting , S , Boekhorst , P A W T , Westerman , M , Schouten , H C & Zweegman , S 2019 , ' Ruxolitinib in Myelofibrosis and Baseline Thrombocytopenia in Real Life : Results in Dutch Patients and Review of the Literature ' , Clinical lymphoma myeloma & leukemia , vol. 19 , no. 10 , pp. 624-634 . https://doi.org/10.1016/j.clml.2019.07.005;
2019
Veröffentlicht in: Slot , S , Raymakers , R A P , Schaap , N , Span , L F R , Koene , H R , Kersting , S , Boekhorst , P A W T , Westerman , M , Schouten , H C & Zweegman , S 2019 , ' Ruxolitinib in Myelofibrosis and Baseline Thrombocytopenia in Real Life : Results in Dutch Patients and Review of the Literature ' , Clinical lymphoma myeloma & leukemia , vol. 19 , no. 10 , pp. 624-634 . https://doi.org/10.1016/j.clml.2019.07.005;
2019
3
Blankenstein, Stephanie A., Aarts, Maureen J. B., van den Berkmortel, Franchette W. P. J., Boers-Sonderen, Marye J., van den Eertwegh, Alfons J. M., Franken, Margreet G., de Groot, Jan Willem B., Haanen, John B. A. G., Hospers, Geke A. P., Kapiteijn, Ellen, Piersma, Djura, van Rijn, Rozemarijn S., Suijkerbuijk, Karijn P. M., ten Tije, Albert J., van der Veldt, Astrid A. M., Vreugdenhil, Gerard, Wouters, Michel W. J. M., van Akkooi, Alexander C. J.
Veröffentlicht in: Blankenstein , S A , Aarts , M J B , van den Berkmortel , F W P J , Boers-Sonderen , M J , van den Eertwegh , A J M , Franken , M G , de Groot , J W B , Haanen , J B A G , Hospers , G A P , Kapiteijn , E , Piersma , D , van Rijn , R S , Suijkerbuijk , K P M , ten Tije , A J , van der Veldt , A A M , Vreugdenhil , G , Wouters , M W J M & van Akkooi , A C J 2020 , ' Surgery for Unresectable Stage IIIC and IV Melanoma in the Era of New Systemic Therapy ' , Cancers , vol. 12 , no. 5 , 1176 . https://doi.org/10.3390/cancers12051176;
2020
Veröffentlicht in: Blankenstein , S A , Aarts , M J B , van den Berkmortel , F W P J , Boers-Sonderen , M J , van den Eertwegh , A J M , Franken , M G , de Groot , J W B , Haanen , J B A G , Hospers , G A P , Kapiteijn , E , Piersma , D , van Rijn , R S , Suijkerbuijk , K P M , ten Tije , A J , van der Veldt , A A M , Vreugdenhil , G , Wouters , M W J M & van Akkooi , A C J 2020 , ' Surgery for Unresectable Stage IIIC and IV Melanoma in the Era of New Systemic Therapy ' , Cancers , vol. 12 , no. 5 , 1176 . https://doi.org/10.3390/cancers12051176;
2020
4
Westgeest, Hans M., Kuppen, Malou C. P., van den Eertwegh, Alphonsus J. M., de Wit, Ronald, Coenen, Juleon L. L. M., van den Berg, H. P. (Pieter), Mehra, Niven, van Oort, Inge M., Fossion, Laurent M. C. L., Hendriks, Mathijs P., Bloemendal, Haiko J., van de Luijtgaarden, Addy C. M., Huinink, Daan ten Bokkel, van den Bergh, A. C. M. (Fons), van den Bosch, Joan, Polee, Marco B., Weijl, Nir, Bergman, Andre M., Uyl-de Groot, Carin A., Gerritsen, Winald R.
Veröffentlicht in: Westgeest , H M , Kuppen , M C P , van den Eertwegh , A J M , de Wit , R , Coenen , J L L M , van den Berg , H P , Mehra , N , van Oort , I M , Fossion , L M C L , Hendriks , M P , Bloemendal , H J , van de Luijtgaarden , A C M , Huinink , D T B , van den Bergh , A C M , van den Bosch , J , Polee , M B , Weijl , N , Bergman , A M , Uyl-de Groot , C A & Gerritsen , W R 2019 , ' Second-Line Cabazitaxel Treatment in Castration-Resistant Prostate Cancer Clinical Trials Compared to Standard of Care in CAPRI : Observational Study in the Netherlands ' , Clinical genitourinary cancer , vol. 17 , no. 5 , pp. E946-E956 . https://doi.org/10.1016/j.clgc.2019.05.018;
2019
Veröffentlicht in: Westgeest , H M , Kuppen , M C P , van den Eertwegh , A J M , de Wit , R , Coenen , J L L M , van den Berg , H P , Mehra , N , van Oort , I M , Fossion , L M C L , Hendriks , M P , Bloemendal , H J , van de Luijtgaarden , A C M , Huinink , D T B , van den Bergh , A C M , van den Bosch , J , Polee , M B , Weijl , N , Bergman , A M , Uyl-de Groot , C A & Gerritsen , W R 2019 , ' Second-Line Cabazitaxel Treatment in Castration-Resistant Prostate Cancer Clinical Trials Compared to Standard of Care in CAPRI : Observational Study in the Netherlands ' , Clinical genitourinary cancer , vol. 17 , no. 5 , pp. E946-E956 . https://doi.org/10.1016/j.clgc.2019.05.018;
2019
5
Wagner, Anna Dorothea, Grabsch, Heike, Mauer, Murielle, Marreaud, Sandrine, Caballero, Carmela, Thuss-Patience, Peter, Mueller, Lothar, Elme, Annelie, Moehler, Markus Hermann, Martens, Uwe, Kang, Yoon-Koo, Rha, Sun Young, Cats, Annemieke, Tokunaga, Masanori, Lordick, Florian
Veröffentlicht in: Wagner , A D , Grabsch , H , Mauer , M , Marreaud , S , Caballero , C , Thuss-Patience , P , Mueller , L , Elme , A , Moehler , M H , Martens , U , Kang , Y-K , Rha , S Y , Cats , A , Tokunaga , M & Lordick , F 2019 , ' EORTC-1203-GITCG - the "INNOVATION"-trial : Effect of chemotherapy alone versus chemotherapy plus trastuzumab, versus chemotherapy plus trastuzumab plus pertuzumab, in the perioperative treatment of HER2 positive, gastric and gastroesophageal junction adenocarcinoma on pathologic response rate: a randomized phase II-intergroup trial of the EORTC-Gastrointestinal Tract Cancer Group, Korean Cancer Study Group and Dutch Upper GI-Cancer group ' , BMC Cancer , vol. 19 , 494 . https://doi.org/10.1186/s12885-019-5675-4;
2019
Veröffentlicht in: Wagner , A D , Grabsch , H , Mauer , M , Marreaud , S , Caballero , C , Thuss-Patience , P , Mueller , L , Elme , A , Moehler , M H , Martens , U , Kang , Y-K , Rha , S Y , Cats , A , Tokunaga , M & Lordick , F 2019 , ' EORTC-1203-GITCG - the "INNOVATION"-trial : Effect of chemotherapy alone versus chemotherapy plus trastuzumab, versus chemotherapy plus trastuzumab plus pertuzumab, in the perioperative treatment of HER2 positive, gastric and gastroesophageal junction adenocarcinoma on pathologic response rate: a randomized phase II-intergroup trial of the EORTC-Gastrointestinal Tract Cancer Group, Korean Cancer Study Group and Dutch Upper GI-Cancer group ' , BMC Cancer , vol. 19 , 494 . https://doi.org/10.1186/s12885-019-5675-4;
2019
6
Evers, Jelle, Hendriks, Lizza E. L., De Jaeger, Katrien, Wijsman, Robin, De Ruysscher, Dirk, Terhaard, Chris, van der Sangen, Maurice, Siesling, Sabine, Struikmans, Henk, Aarts, Mieke J.
Veröffentlicht in: Evers , J , Hendriks , L E L , De Jaeger , K , Wijsman , R , De Ruysscher , D , Terhaard , C , van der Sangen , M , Siesling , S , Struikmans , H & Aarts , M J 2021 , ' Trends and variations in the treatment of stage I-III small cell lung cancer from 2008 to 2019 : A nationwide population-based study from the Netherlands ' , Lung Cancer , vol. 162 , pp. 61-70 . https://doi.org/10.1016/j.lungcan.2021.10.011;
2021
Veröffentlicht in: Evers , J , Hendriks , L E L , De Jaeger , K , Wijsman , R , De Ruysscher , D , Terhaard , C , van der Sangen , M , Siesling , S , Struikmans , H & Aarts , M J 2021 , ' Trends and variations in the treatment of stage I-III small cell lung cancer from 2008 to 2019 : A nationwide population-based study from the Netherlands ' , Lung Cancer , vol. 162 , pp. 61-70 . https://doi.org/10.1016/j.lungcan.2021.10.011;
2021
7
Evers, J., Hendriks, L.E.L., De Jaeger, K., Wijsman, R., De Ruysscher, D., Terhaard, C., van der Sangen, M., Siesling, S., Struikmans, H., Aarts, M.J.
Veröffentlicht in: Evers , J , Hendriks , L E L , De Jaeger , K , Wijsman , R , De Ruysscher , D , Terhaard , C , van der Sangen , M , Siesling , S , Struikmans , H & Aarts , M J 2021 , ' Trends and variations in the treatment of stage I-III small cell lung cancer from 2008 to 2019: A nationwide population-based study from the Netherlands ' , Lung Cancer , vol. 162 , pp. 61-70 . https://doi.org/10.1016/j.lungcan.2021.10.011;
2021
Veröffentlicht in: Evers , J , Hendriks , L E L , De Jaeger , K , Wijsman , R , De Ruysscher , D , Terhaard , C , van der Sangen , M , Siesling , S , Struikmans , H & Aarts , M J 2021 , ' Trends and variations in the treatment of stage I-III small cell lung cancer from 2008 to 2019: A nationwide population-based study from the Netherlands ' , Lung Cancer , vol. 162 , pp. 61-70 . https://doi.org/10.1016/j.lungcan.2021.10.011;
2021
8
Swart, Esther M., Noordhof, Anneloes L., Damhuis, Ronald A. M., Kunst, Peter W. A., De Ruysscher, Dirk K. M., Hendriks, Lizza E. L., van Geffen, Wouter H., Aarts, Mieke J.
Veröffentlicht in: Swart , E M , Noordhof , A L , Damhuis , R A M , Kunst , P W A , De Ruysscher , D K M , Hendriks , L E L , van Geffen , W H & Aarts , M J 2023 , ' Survival of patients with KRAS G12C mutated stage IV non-small cell lung cancer with and without brain metastases treated with immune checkpoint inhibitors ' , Lung Cancer , vol. 182 , no. 1 , 107290 . https://doi.org/10.1016/j.lungcan.2023.107290;
2023
Veröffentlicht in: Swart , E M , Noordhof , A L , Damhuis , R A M , Kunst , P W A , De Ruysscher , D K M , Hendriks , L E L , van Geffen , W H & Aarts , M J 2023 , ' Survival of patients with KRAS G12C mutated stage IV non-small cell lung cancer with and without brain metastases treated with immune checkpoint inhibitors ' , Lung Cancer , vol. 182 , no. 1 , 107290 . https://doi.org/10.1016/j.lungcan.2023.107290;
2023
9
Fahrleitner-Pammer, A., Papaioannou, N., Gielen, E., Tepie, M. Feudjo, Toffis, C., Frieling, I., Geusens, P., Makras, P., Boschitsch, E., Callens, J., Anastasilakis, A. D., Niedhart, C., Resch, H., Kalouche-Khalil, L., Hadji, P.
Veröffentlicht in: Fahrleitner-Pammer , A , Papaioannou , N , Gielen , E , Tepie , M F , Toffis , C , Frieling , I , Geusens , P , Makras , P , Boschitsch , E , Callens , J , Anastasilakis , A D , Niedhart , C , Resch , H , Kalouche-Khalil , L & Hadji , P 2017 , ' Factors associated with high 24-month persistence with denosumab : results of a real-world, non-interventional study of women with postmenopausal osteoporosis in Germany, Austria, Greece, and Belgium ' , Archives of Osteoporosis , vol. 12 , no. 1 , 58 . https://doi.org/10.1007/s11657-017-0351-2;
2017
Veröffentlicht in: Fahrleitner-Pammer , A , Papaioannou , N , Gielen , E , Tepie , M F , Toffis , C , Frieling , I , Geusens , P , Makras , P , Boschitsch , E , Callens , J , Anastasilakis , A D , Niedhart , C , Resch , H , Kalouche-Khalil , L & Hadji , P 2017 , ' Factors associated with high 24-month persistence with denosumab : results of a real-world, non-interventional study of women with postmenopausal osteoporosis in Germany, Austria, Greece, and Belgium ' , Archives of Osteoporosis , vol. 12 , no. 1 , 58 . https://doi.org/10.1007/s11657-017-0351-2;
2017
10
Breugom, A. J., Bastiaannet, E., Boelens, P. G., Van Eycken, E., Iversen, L. H., Martling, A., Johansson, R., Evans, T., Lawton, S., O'Brien, K. M., Ortiz, H., Janciauskiene, R., Dekkers, O. M., Rutten, H. J. T., Liefers, G. J., Lemmens, V. E. P. P., van de Velde, C. J. H.
Veröffentlicht in: Breugom , A J , Bastiaannet , E , Boelens , P G , Van Eycken , E , Iversen , L H , Martling , A , Johansson , R , Evans , T , Lawton , S , O'Brien , K M , Ortiz , H , Janciauskiene , R , Dekkers , O M , Rutten , H J T , Liefers , G J , Lemmens , V E P P & van de Velde , C J H 2018 , ' Oncologic treatment strategies and relative survival of patients with stage I-III rectal cancer - A EURECCA international comparison between the Netherlands, Belgium, Denmark, Sweden, England, Ireland, Spain, and Lithuania ' , European Journal of Surgical Oncology , vol. 44 , no. 9 , pp. 1338-1343 . https://doi.org/10.1016/j.ejso.2018.05.025;
2018
Veröffentlicht in: Breugom , A J , Bastiaannet , E , Boelens , P G , Van Eycken , E , Iversen , L H , Martling , A , Johansson , R , Evans , T , Lawton , S , O'Brien , K M , Ortiz , H , Janciauskiene , R , Dekkers , O M , Rutten , H J T , Liefers , G J , Lemmens , V E P P & van de Velde , C J H 2018 , ' Oncologic treatment strategies and relative survival of patients with stage I-III rectal cancer - A EURECCA international comparison between the Netherlands, Belgium, Denmark, Sweden, England, Ireland, Spain, and Lithuania ' , European Journal of Surgical Oncology , vol. 44 , no. 9 , pp. 1338-1343 . https://doi.org/10.1016/j.ejso.2018.05.025;
2018